Xcel Brands (XELB) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
22 Oct, 2026Executive summary
Annual meeting scheduled for Dec. 18, 2026; record date Oct. 27, 2026. Board unanimously recommends FOR all four listed proposals and the five director nominees.
Proposals cover director elections, Wolf & Company, PC auditor ratification, a 650,000-share increase to the 2021 Plan, and issuance above 19.99% of common stock upon default-related note conversion.
Voting matters and shareholder proposals
Five incumbent directors are nominated for one-year terms: Robert W. D’Loren, Mark DiSanto, James Fielding, Howard Liebman, and Deborah Weinswig.
Ratification seeks approval of Wolf & Company, PC for FY2026; the Audit Committee may change auditors during the year if it considers a change in stockholders’ interests.
The 2021 Plan proposal would raise shares reserved for awards from 1,150,000 to 1,800,000; the Board cites recruitment, retention, and incentives for growth and profitability.
Director elections require a majority of votes cast by shares present and entitled to vote; the other proposals require a majority of shares present and entitled to vote.
Board of directors and corporate governance
Four directors—Liebman, DiSanto, Fielding, and Weinswig—are deemed independent; all standing committees consist solely of independent directors.
CEO Robert W. D’Loren also serves as Board Chair; the Board supports unified leadership, has no lead independent director, and relies on independent committees and executive sessions for oversight.
In 2025, the Board held three meetings; directors each attended at least 75% of relevant Board and committee meetings. The Audit Committee held four meetings; the other two committees acted by written consent.
Latest events from Xcel Brands
- Shareholders face three votes, including a 650,000-share equity-plan increase.XELB
Proxy filing - Q2 2026 saw lower revenue but improved net loss, with ongoing liquidity and growth challenges.XELB
Q2 2026 - Net loss narrowed, revenue fell, and liquidity improved, but going concern risks persist.XELB
Q1 2026 - Registration of 13.6M shares for resale may cause significant dilution and price impact.XELB
Registration filing - Year-over-year losses narrowed as influencer-led brands and cost cuts set up 2026 growth.XELB
Q4 2025 - Licensing-driven company registers 13.6M shares for resale amid ongoing financial risk.XELB
Registration Filing - Vote on reverse split and share reduction to maintain Nasdaq listing and manage tax costs.XELB
Proxy Filing - Licensing model, cost cuts, and new term loan set up growth and improved liquidity in 2024.XELB
Q3 2024 - Q2 2024 net income hit $0.2M as licensing growth and cost cuts offset wholesale exit.XELB
Q2 2024